Catherine C. Lee

Insider Reports History

Location
San Diego, CA
Signature
/s/ Catherine C. Lee
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine C. Lee:

Company Role Class Num Shares Value Price $ Report Date Ownership
Metacrine, Inc. EVP, Gen. Counsel & Secretary Common Stock 3,846 $1,808 $0.4700 05 May 2021 Direct
TFF Pharmaceuticals, Inc. Director Restricted stock units 3,556 $1,393 $0.3916 18 Apr 2024 Direct
TFF Pharmaceuticals, Inc. Director Common Stock 1,583 $620 $0.3916 03 Jul 2024 Direct
TFF Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 1,583 03 Jul 2024 Direct

Insider Reports Filed by Catherine C. Lee

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000121390024059877-lee-catherine-chai-zon-2024-07-03 TFF Pharmaceuticals, Inc. 03 Jul 2024 2 $0 4 Director 08 Jul 2024, 17:44
/report/000121390024035083-lee-catherine-chai-zon-2024-04-18 TFF Pharmaceuticals, Inc. 18 Apr 2024 1 $0 4 Director 22 Apr 2024, 20:52
/report/000121390023092816-lee-catherine-chai-zon-2023-12-01 TFF Pharmaceuticals, Inc. 01 Dec 2023 1 $0 4 Director 04 Dec 2023, 17:27
/report/000121390023092811-lee-catherine-chai-zon-2023-12-01 TFF Pharmaceuticals, Inc. 01 Dec 2023 0 $0 3 Director 04 Dec 2023, 17:25
/report/000120919121031049-lee-catherine-chai-zon-2021-05-05 Metacrine, Inc. 05 May 2021 1 $0 4 EVP, Gen. Counsel & Secretary 07 May 2021, 18:36